vTv Therapeutics Inc. (VTVT) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VTVT Revenue Growth
Revenue Breakdown (FY 2024)
VTVT's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
VTVT Revenue Analysis (2014–2025)
As of May 8, 2026, vTv Therapeutics Inc. (VTVT) generated trailing twelve-month (TTM) revenue of $-24,000, reflecting significant decline in growth of -241.2% year-over-year. The most recent quarter (Q4 2025) recorded $-24,000 in revenue.
Looking at the longer-term picture, VTVT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $12.4 million in 2018.
Revenue diversification analysis shows VTVT's business is primarily driven by Reportable Segment (100%). With over half of revenue concentrated in Reportable Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including PRTA (-58.0% YoY), and NRXP, VTVT has underperformed the peer group in terms of revenue growth. Compare VTVT vs PRTA →
VTVT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| VTVTCurrent | $-24,000 | -241.2% | - | - | |
 PRTA | $10M | -58.0% | +62.6% | -1905.8% | |
 NRXP | $1M | - | - | -1324.4% |
VTVT Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | -100.0% | $-16,000 | - | $-32,808,000 | - |
| 2024 | $1.0M | - | $1.0M | 100.0% | $-24,180,000 | -2377.6% |
| 2023 | $0 | -100.0% | $0 | - | $-25,502,000 | - |
| 2022 | $2.0M | -49.6% | $2.0M | 100.0% | $-22,540,000 | -1116.9% |
| 2021 | $4.0M | -37.6% | $4.0M | 100.0% | $-21,662,000 | -540.9% |
| 2020 | $6.4M | +132.1% | $-4,601,000 | -71.7% | $-11,852,000 | -184.8% |
| 2019 | $2.8M | -77.8% | $-12,355,000 | -447.0% | $-20,892,000 | -755.9% |
| 2018 | $12.4M | +4172.9% | $-10,601,000 | -85.3% | $-19,824,000 | -159.4% |
| 2017 | $291K | -54.1% | $-39,349,000 | -13522.0% | $-50,682,000 | -17416.5% |
| 2016 | $634K | +22.2% | $-45,114,000 | -7115.8% | $-55,020,000 | -8678.2% |
See VTVT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VTVT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VTVT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVTVT — Frequently Asked Questions
Quick answers to the most common questions about buying VTVT stock.
Is VTVT's revenue growth accelerating or slowing?
VTVT revenue declined -241.2% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $-24000.00. This reverses the prior growth trend.
What is VTVT's long-term revenue growth rate?
vTv Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -241.2% is below this long-term average.
How is VTVT's revenue distributed by segment?
VTVT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.